Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage ...
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company ...
Zacks Investment Research on MSN
Armata Pharmaceuticals, Inc. (ARMP) Reports Q3 Loss, Misses Revenue Estimates
Armata Pharmaceuticals, Inc. (ARMP) came out with a quarterly loss of $0.42 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.15 per share a year ago. These figures ...
Armata Pharmaceuticals ( ARMP) announced Thursday that it has closed the second and final tranche of its previously announced private placement with Innoviva Strategic Opportunities, a wholly-owned ...
The T-14 Armata, Russia’s next-generation tank, is finally nearing readiness. However, information on recent development has been scarce. A recent interview in February 2018 with Vyacheslav Khalitov, ...
RedEffect Official on MSN
Proof that T-14 Armata is in Ukraine
Russian journalist Solovyev made a post with some very interesting T-14 Armata footage with a caption “Armata goes west”, ...
Summary: The T-14 Armata tank, unveiled in 2015, was intended to be a revolutionary advancement in armored warfare. -Featuring an unmanned turret, advanced armor, and a new 125mm smoothbore cannon, it ...
Russia is building a supertank. Last month, we told you about Russia's new Armata main battle tank -- the tank with which it will roll into the 21st century. But did you know that the Armata is more ...
View original content to download multimedia:https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-third-quarter-2025-results-and-provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback